Administration of anti-IL-25 and anti-TSLP antibodies during ovalbumin-induced asthma could reduce the infiltration of inflammatory cells into airways, as well as local expression of IL-4, IL-5 and IL-13. This evidence concerns the gene TSLP and asthma.